Rheumatology

Publications

Acharya, NR; Ramanan, AV; Coyne, AB; Dudum, KL; Rubio, EM; Woods, SM; Guly, CM; Moraitis, E; Petrushkin, HJD; Armon, K; Puvanachandra, N; Choi, JT; Hawley, DP; Arnold, BF. Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial. The Lancet. 2025; 405(10475):303-313.

Arnaud, L; Ruiz-Irastorza, G; Aranow, C; Bernatsky, S; Dall'era, M; Adelowo, O; Bae, S-C; Beretta, L; Bonfa, E; Cervera, R; Gerosa, M; Touma, Z; Mosca, M; Tani, C. ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations. The Lancet Rheumatology. 2025; 7(7):e505-e518.

Baldo, F; Erkens, RGA; Mizuta, M; Rogani, G; Lucioni, F; Bracaglia, C; Foell, D; Gattorno, M; Jelusic, M; Anton, J; Ruperto, N; Swart, JF; Vastert, S; Minoia, F. Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. Rheumatology. 2025; 64(1):32-44.

Barraclough, M; Mckie, S; Rittner, L; Knight, A; Katz, P; Hanly, J; Legge, A; Mackay, M; Dobrowolski, C; Brunner, H; Parker, B; Bruce, I; Touma, Z; Appenzeller, S. INTERNATIONAL EFFORT IN HARMONIZING COGNITIVE IMPAIRMENT RESEARCH IN SYSTEMIC LUPUS ERYTHEMATOSUS. Journal of Rheumatology. 2025; 52(Suppl 1):39-40.

Basaran, O; Sag, E; Aydın, EA; Aydın, B; Tasdemir, NK; Celikel, E; Bayındır, Y; Özdel, S; Bilginer, Y; Grom, AA; Ozen, S. Lack of HLH in FMF. Pediatric Rheumatology. 2025; 23(1):14.

Brandon, TG; Xiao, R; Lovell, DJ; Oberle, E; Stoll, ML; Chauvin, NA; Francavilla, ML; Maksymowych, WP; Weiss, PF. Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease. Arthritis & Rheumatology. 2025.

Brandon, TG; Xiao, R; Lovell, DJ; Oberle, E; Stoll, ML; Chauvin, NA; Francavilla, ML; Maksymowych, WP; Weiss, PF. Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis. Arthritis Care and Research. 2025; 77(10):1229-1239.

Brunner, HI; Antón, J; Calvo-Penadés, I; Dimelow, R; Horneff, G; Kamphuis, S; Marino, R; Van Maurik, A; Minden, K; Mori, M; Ocran-Appiah, J; Wilkinson, C; Yamasaki, Y; Assudani, D. Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial. Arthritis Care and Research. 2025.

Brunner, HI; Cody, EM; Devarajan, P; Huang, B; Chen, C; Sinibaldi, D; Ramaswamy, M; Knagenhjelm, J; Jones, F; Brohawn, PZ; Tummala, R; Lindholm, C; White, WI. The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis. Arthritis Care and Research. 2025.

Brunner, HI; Shmagel, A; Horneff, G; Foeldvari, I; Antón, J; Ramanan, AV; Qian, Y; Unnebrink, K; Hao, S; Camp, HS; Khan, N; Liu, W; Mohamed, M-EF. Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open-Label, Phase 1 Trial. Arthritis Care and Research. 2025; 77(5):584-593.

Brunner, HI; Alexeeva, E; Bandeira, M; Carrasco, R; Chaitow, J; Chiraseveenuprapund, P; Ting, TV; Erguven, M; Gottlieb, B; Oliveira, SK; Stockert, L; Martini, A; Lovell, DJ; Ruperto, N. Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial. Arthritis & Rheumatology. 2025.

Case, S; Hill, CL; Shrader, P; Dennos, A; Phillips, T; Schanberg, LE; Von Scheven, E; Barbour, K; Knight, AM; Hersh, A; Son, M. Disease activity trajectories in paediatric lupus and associations with socioeconomic factors and patient-reported pain. Lupus Science and Medicine. 2025; 12(2).

Cody, EM; Sproles, A; Rose, J; Huang, B; Devarajan, P; Brunner, HI; Thornton, S. Development and Validation of Multiplex Assays for Lupus Nephritis Activity Biomarkers. Kidney International Reports. 2025; 10(7):2255-2264.

Connelly, K; Koelmeyer, R; Ayton, D; May, J; Gregory, K; Eades, LE; Barallon, R; Kandane-Rathnayake, R; Golder, V; Anzum, A; Furie, RA; Van Vollenhoven, RF; Banerjee, S; Morand, E. Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study. Lupus Science and Medicine. 2025; 12(1).

Consolaro, A; Ruperto, N; Lovell, DJ; Synoverska, O; Abud-Mendoza, C; Spindler, A; Vyzhga, Y; Alexeeva, E; Chaitow, J; Chiraseveenuprapund, P; Lazariciu, I; Stockert, L; Cadatal, MJ; Diehl, A; Brunner, HI. Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial. Journal of Rheumatology. 2025; 52(9):919-926.

Cook, E; Schulert, G; Grom, A; Towe, C; Burg, G; Marsh, R; Chandra, S. Experience with T Cell–Depleted Allogeneic HSCT for Refractory sJIA Associated with Lung Disease. Journal of Human Immunity. 2025; 1(CIS2025).

Correll, C; Burciu, A; Bansal, A; Dennos, A; Narayanswamy, D; Aubrun, E; Schanberg, LE; Yuhan, L; Schneider, R; Balevic, S; Kimura, Y; Beukelman, T. Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. Pediatric Rheumatology. 2025; 23(1):105.

Cunningham, NR; Danguecan, AN; Ely, SL; Amponsah, Y; Davis, A; Edison, S; Harris, J; Jones, JT; Goldstein-Leever, A; Manning, A; Treemarcki, E; Winner, K; Rubinstein, TB; Knight, AM. American College of Rheumatology Guidance Statements for Addressing Mental Health Concerns in Youth With Pediatric Rheumatologic Diseases. Arthritis Care and Research. 2025; 77(8):953-964.

Cunningham, NR; Senger-Carpenter, T; Zuckerman, J; Adler, M; Reid, MR; Danguecan, A; Pereira, LF; Mossad, SI; Ely, SL; Abulaban, K; Brunner, HI; Reeves, M; Pierce, SJ; Knight, A. Cognitive Behavioral Therapy for Youth with Childhood-Onset Lupus: A Randomized Clinical Trial. Arthritis Care and Research. 2025.

De Lisa, R; De Andres-Trelles, F; Bax, R; Galluzzo, S; Alward, B; Thomson, A; Karres, D; Brunner, HI; Ruperto, N; Egger, GF. New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development. Frontiers in Medicine. 2025; 12:1583140.

Difrancesco, M; Wilson, E; Brunner, H. POS1400 PERIVENTRICULAR ABNORMALITY GRADIENTS OF RELAXOMETRY AND SUSCEPTIBILITY METRICS BY NEUROIMAGING: COMPARING LUPUS AND MULTIPLE SCLEROSIS. Annals of the Rheumatic Diseases. 2025; 84:1421-1422.

Difrancesco, M; Brunner, H. VOLUME AND DYNAMIC BLOOD FLOW OF THE CHOROID PLEXUS IN NEUROINFLAMMATORY DISEASE. Journal of Rheumatology. 2025; 52(Suppl 1):106-107.

Eloseily, E; Pickering, A; Dhakal, S; Ruperto, N; Brunner, HI; Grom, AA; Thornton, S. Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction. Arthritis Care and Research. 2025; 77(4):513-521.

Eloseily, E; Romankevych, I; Sabit, T; Berklite, L; Ranganathan, S; Rosen, P; Henrickson, M; Huggins, J; Schulert, G; Grom, A. Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Journal of Rheumatology. 2025.

Eloseily, E; Riordan, ME; Mahmoud, I; Clark, A; Chang, M-L; Russell, A; Natter, M; Thornton, S; Canna, S; Co, DO; Deguzman, M; Kimura, Y; Schulert, GS. Baseline Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis- Associated Lung Disease Cohort. Arthritis Care and Research. 2025.

Esteban, Y; Avar-Aydin, PO; Ting, TV; Cassedy, A; Vega-Fernandez, P. Sonographic and Disease Activity Findings Related With Medication Change in JIA: A Historical Cohort Study. Journal of Clinical Rheumatology. 2025; 31(1):20-25.

Estel, GJP; Quintana, R; Nieto, R; Brunner, H; Scolnik, M; Soaje, CF; Alba, P; Saurit, V; García, MA; Berbotto, G; Zazzetti, F; Orillion, A; Sbarigia, U; Pons-Estel, B. POS0841 THE RENAL ACTIVITY INDEX FOR LUPUS IDENTIFIES AND PREDICTS COMPLETE RENAL REMISSION OR ABSENCE OF KIDNEY INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 2025; 84:985-986.

Foeldvari, I; Solebo, A; Petrushkin, H; Angeles-Han, ST; Bangsgaard, R; Calzada-Hernández, J; Constantin, T; De Boer, J; Díaz-Cascajosa, J; Glerup, M; Simonini, G; Swart, JF; Titz, J; Antón, J. Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood. Arthritis Care and Research. 2025; 77(9):1106-1111.

Foeldvari, I; Bohn, M; Petrushkin, H; Angeles Han, S; Bangsgaard, R; Calzada-Hernández, J; Constantin, T; De Boer, JH; Díaz-Cascajosa, J; Edelsten, C; Simonini, G; Solebo, AL; Titz, J; Anton, J. A practical approach to uveitis screening in children with juvenile idiopathic arthritis. British Journal of Ophthalmology. 2025; 109(3):372-376.

Hamdi, W; Migowa, A; Ferjani, HL; Makhloufi, CD; Makhlouf, Y; Nasef, SI; Ziade, N; Baraliakos, X; Brunner, H; Hassan, M; Furia, FF; Slimani, S; Scott, C; Hadef, D. Pediatric Society of the African League Against Rheumatism juvenile idiopathic arthritis recommendations for enthesitis-related arthritis and juvenile psoriatic arthritis. Clinical Rheumatology. 2025; 44(3):901-922.

Henderson, LA; Abraham, RS; Ahmed, A; Blount, L; Canna, SW; Chaimowitz, NS; Chandrakasan, S; Coates, B; Connelly, JA; Cooper, MA; Vogel, T; Walkovich, K; Zinter, MS; Behrens, EM. Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation. Frontiers in Immunology. 2025; 16:1519955.

Jones, OY; Mccurdy, DK; Spencer, CH; Lovell, DJ. Juvenile Idiopathic Arthritis-The Rubik's Cube of Pediatric Rheumatology. Children. 2025; 12(10).

Kasap-Cuceoglu, M; Huggins, J; Ting, T; Smith-Rodriguez, J; Merritt, A; Brunner, H. POS1172 EVALUATING THE STANDARDIZED STEROID REGIMEN (SSR) FOR CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RETROSPECTIVE INSIGHTS FROM REAL-WORLD DATA. Annals of the Rheumatic Diseases. 2025; 84:1242-1243.

Kudira, R; Yang, ZF; Osuji, I; Damen, MSMA; Yang Vom Hofe, A; Singh, M; Karns, R; Bariya, P; Pfuhler, L; Mullen, M; Subramanian, S; Salomonis, N; Miraldi, ER; Miethke, AG. Bile acids engage the SIPR-STAT3 signaling axis to modulate regulatory T cell responses in fibrosing cholangiopathies. Journal of Hepatology. 2025; 83(5):1128-1141.

Li, Y; Huang, B; Andorf, S; Yue, X; Lovell, DJ; Brunner, HI. Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease-Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta-Analysis of Randomized Controlled Trials. ACR Open Rheumatology. 2025; 7(2):e11788.

Macaraeg, M; Sood, A; Guner, ME; Guner, MK; Schulert, G; Mahajan, VB; Utz, VM; Angeles-Han, ST. Genetic Inflammatory Diseases with Ocular Involvement. In: Genetic Diseases of the Eye. Oxford University Press (OUP); 2025:1070-1091.

Macaraeg, M; Baker, E; Handorf, E; Matt, M; Baker, EK; Brunner, H; Grom, AA; Henrickson, M; Huggins, J; Zhang, W; Lee, P; Marsh, R; Schulert, GS. Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers. Arthritis & Rheumatology. 2025; 77(5):596-605.

Maccora, I; Altaye, M; Greis, KD; Brunner, HI; Duell, A; Haffey, WD; Nguyen, T; Quinlan-Waters, M; Schulert, GS; Sproles, A; Utz, VM; Thornton, S; Angeles-Han, ST. Candidate Tear-Based Uveitis Biomarkers in Children with JIA Based on Arthritis Activity and Topical Corticosteroid Use. Ocular Immunology and Inflammation. 2025; 33(4):603-612.

Maccora, I; Brunner, HI; Cassedy, A; Altaye, M; Quinlan-Waters, M; Lovell, DJ; Grom, A; Angeles-Han, ST. Achieving Medication-Free Remission in Patients With Juvenile Dermatomyositis. ACR Open Rheumatology. 2025; 7(1):e11751.

Mannion, ML; Aswani, MS; Hearld, KR; Smitherman, EA; Timmerman, L; Curtis, JR. Disease activity at two consecutive registry visits and subsequent medication escalation for patients with juvenile idiopathic arthritis in the CARRA registry. Pediatric Rheumatology. 2025; 23(1):77.

Matt, MG; Drozdov, D; Bendstrup, E; Glerup, M; Hauge, E-M; Masmas, T; Schneider, EC; Zeilhofer, UB; Abu-Arja, RF; Driest, KD; Chandra, S; Grom, A; Schulert, GS; Marsh, RA. Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study. The Lancet Rheumatology. 2025; 7(4):e243-e251.

Miraldi Utz, V; Angeles-Han, ST. Global Perspectives on Paediatric Uveitis: Bridging the Divide in Child-Centered Ocular Care. Ocular Immunology and Inflammation. 2025; 33(10):2241-2244.

Mönkemöller, K; Weber, LT; Häusler, M; Kallinich, T; Benseler, S; Brunner, HI; Bieber, C; Brunner, J; Deuter, C; Hahn, G; Tönshoff, B; Tenbrock, K; Haffner, D; Schuetz, C. Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus. EULAR Rheumatology Open. 2025; 1(4):380-393.

Nguyen, K; Yasin, S; Fall, N; Grom, AA; Brunner, HI; Towe, C; Schulert, GS. Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis. Pediatric Rheumatology. 2025; 23(1):74.

O'connor, SK; Devarajan, P; Liu, J; Maldonado, MA; Sproles, A; Rose, J; Thornton, S; Chen, C; Huang, B; Brunner, HI. The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients with Lupus Nephritis. Journal of Rheumatology. 2025.

Ogbu, EA; Sagcal-Gironella, ACP; Eberhard, BA; Huggins, JM; Klein-Gitelman, MS; Onel, K; Chen, C; Huang, B; Brunner, HI. Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale. ACR Open Rheumatology. 2025; 7(1):e11737.

Ogbu, EA; Brunner, HI; Imundo, L. 41 Systemic lupus erythematosus in childhood and adolescence. In: Dubois' Lupus Erythematosus and Related Syndromes. Elsevier; 2025:580-595.

Ohnishi, T; Wilkerson, J; Bayat, N; Farhadi, PN; Faiq, A; Dillon, CF; Schiffenbauer, A; Parks, CG; Brunner, HI; Goldberg, B; Miller, FW; Rider, LG. Infections preceding diagnosis associated with myositis phenotypes in a national patient registry. Clinical and Experimental Rheumatology. 2025; 43(7):1204-1212.

Parks, CG; Wilkerson, J; Rose, KM; Faiq, A; Farhadi, PN; Bayat, N; Schiffenbauer, A; Brunner, HI; Goldberg, B; Sandler, DP; Miller, FW; Rider, LG. Occupational and Hobby Exposures Associated With Myositis Phenotypes in a National Myositis Patient Registry. Arthritis Care and Research. 2025; 77(1):104-115.

Pence, LJ; Aundhia, MA; Alanni, J; Jackson, AK; Lovell, DJ; Soe, KC. Post-Streptococcal Myositis: Etiology of Myalgia and Severe Inflammation in a Child. Pediatrics. 2025; 156(6).

Randell, RL; Schanberg, LE; Beard, C; Phillips, T; Hornik, CP; Cohen-Wolkowiez, M; Balevic, SJ. Effect of an Electronic Pill Bottle on Hydroxychloroquine Adherence in Pediatric Lupus: Results of a Novel Direct-to-Family Pilot Trial. ACR Open Rheumatology. 2025; 7(1):e11780.

Ringold, S; Ong, M-S; Tomlinson, G; Natter, MD; Schanberg, LE; Del Gaizo, V; Feldman, BM; Murphy, KL; Kimura, Y. Three-Year Outcomes and Latent Class Trajectory Analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular JIA Consensus Treatment Plans Study. Arthritis & Rheumatology. 2025; 77(10):1433-1441.

Romankevych, I; Singer, N; Huggins, J; Marathe, K; Merritt, A; Chen, C; Stockert, L; Pelletier, K; Wang, X; Shi, H; Huang, B; Brunner, H. Pharmacokinetics, effectiveness, tolerability and effect on quality of life of open-label tofacitinib for the treatment of moderately active mucocutaneous manifestations of SLE: results of a 76-week phase II study. Lupus Science and Medicine. 2025; 12(2).

Rosenbaum, D; Meyers, AB; Vega-Fernandez, P; Hailu, SS; Yaya-Quezada, C; Nguyen, JC. Juvenile Idiopathic Arthritis and Spondylarthritis. Seminars in Musculoskeletal Radiology. 2025; 29(2):249-266.

Ruperto, N; Lovell, DJ; Synoverska, O; Abud-Mendoza, C; Spindler, A; Vyzhga, Y; Reyhan, I; Grebenkina, L; Tirosh, I; Imundo, L; Ebrahim, A; Klaus, P; Martini, A; Brunner, HI. Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial. ACR Open Rheumatology. 2025; 7(10):e70097.

Ruperto, N; Li, C; Chinniah, K; Uziel, Y; Synoverska, O; Sawhney, S; Calvo, I; Louw, I; Lu, M; Patel, PN; Koch, GG; Martini, A; Lovell, DJ; Brunner, H. OP0212 EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. Annals of the Rheumatic Diseases. 2025; 84:176-177.

Rypdal, V; Brunner, HI; Feldman, BM; Ruperto, N; Aggarwal, A; Angeles-Han, ST; Backström, M; Balay-Dustrude, E; Bracaglia, C; De Benedetti, F; Vojinovic, J; Weiss, PF; Gottlieb, B; Consolaro, A. Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force. Annals of the Rheumatic Diseases. 2025; 84(8):1425-1436.

Sadun, RE; Cooper, JC; Belot, A; Avcin, T; Aggarwal, A; Ainsworth, J; Akinsete, A; Ardoin, SP; Beresford, MW; Bortey, L; Wenderfer, SE; Woodside, A; Lewandowski, LB; Smith, EM. Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. Annals of the Rheumatic Diseases. 2025; 84(2):158-168.

Sammaritano, LR; Askanase, A; Bermas, BL; Dall'era, M; Duarte-García, A; Hiraki, LT; Son, MBF; Werth, VP; Aranow, C; Barnado, A; Turgunbaev, M; Williams, JN; Turner, AS; Mustafa, RA. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus. Arthritis & Rheumatology. 2025.

Sammaritano, LR; Askanase, A; Bermas, BL; Dall'era, M; Duarte-García, A; Hiraki, LT; Son, MBF; Werth, VP; Aranow, C; Barnado, A; Turgunbaev, M; Williams, JN; Turner, AS; Mustafa, RA. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus. Arthritis Care and Research. 2025.

Sammaritano, LR; Askanase, A; Bermas, BL; Dall'era, M; Duarte-García, A; Hiraki, LT; Rovin, BH; Son, MBF; Alvarado, A; Aranow, C; Turgunbaev, M; Williams, JN; Turner, AS; Mustafa, RA. 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Care and Research. 2025; 77(9):1045-1065.

Sammaritano, LR; Askanase, A; Bermas, BL; Dall'era, M; Duarte-García, A; Hiraki, LT; Rovin, BH; Son, MBF; Alvarado, A; Aranow, C; Turgunbaev, M; Williams, JN; Turner, AS; Mustafa, RA. 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis & Rheumatology. 2025; 77(9):1115-1135.

Sandborg, CI; Schulert, GS; Kimura, Y. Juvenile Idiopathic Arthritis. New England Journal of Medicine. 2025; 393(2):162-174.

Schulert, GS. Update on new autoinflammatory disorders from the 2024 Pediatric Rheumatology European Society Congress. Pediatric Rheumatology. 2025; 23(1):107.

Shahin, MM; Gorell, ES; Iqneibi, M; Sun, Q; Brunner, HI; Hellmann, J; Marathe, KS. Characterization of TNF‐Alpha Inhibitor Induced Paradoxical Psoriasiform Dermatitis at a Single Center via Retrospective Chart Review. Pediatric Dermatology. 2025.

Shalen, J; Austenfeld, E; Vater, M; Curran, M; Hayward, K; Mehta, J; Gillispie-Taylor, M. Essential Areas of Knowledge in Rheumatology for Pediatric Residents: A Modified Delphi Study. Pediatrics. 2025; 156(1).

Shishov, M; Weiss, PF; Levy, DM; Chang, JC; Angeles-Han, ST; Ogbu, EA; Nanda, K; Sherrard, TM; Goldmuntz, E; Lovell, DJ; Rider, LG; Brunner, HI. 25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges. Arthritis Care and Research. 2025; 77(5):573-583.

Soulsby, WD; Olveda, R; He, J; Berbert, L; Weller, E; Barbour, KE; Greenlund, KJ; Schanberg, LE; Von Scheven, E; Hersh, A; Son, MBF; Chang, J; Knight, A. Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study. Arthritis Care and Research. 2025; 77(1):38-49.

Tursi, AR; Lages, CS; Quayle, K; Koenig, ZT; Loni, R; Eswar, S; Cobeña-Reyes, J; Thornton, S; Tilburgs, T; Andorf, S. Automated descriptive cell type naming in flow and mass cytometry with CytoPheno. Scientific Reports. 2025; 15(1):26750.

Utz, VM; Cassedy, A; Duell, A; Quinlan-Waters, M; Kaufman, AH; Angeles-Han, S. 116 Clinical characteristics and quality of life measures in children with glaucoma suspect or glaucoma diagnoses in chronic, non-infectious uveitis. Journal of AAPOS. 2025; 29(4):104398.

Vega-Fernandez, P; Avar-Aydin, PO; Rogers, K; Lovell, DJ; Huggins, J; Grom, A; Brunner, HI; Schulert, GS; Angeles-Han, ST; Altaye, M; Cassedy, A; Meyers, AB; Ting, TV. Validation of the Pediatric Arthritis Ultrasound Scoring System for the Elbow, Wrist, and Finger Joints in Children with Juvenile Idiopathic Arthritis. Arthritis Care and Research. 2025.

Vega-Fernandez, P; Huggins, J; Angeles-Han, S; Lovell, DJ; Brunner, H; Rogers, K; Quinlan-Waters, M; Thornton, S; Cassedy, A; Ting, T. POS0295 RELATIONSHIP AMONG A PEDIATRIC-SPECIFIC ULTRASOUND SCORING SYSTEM FOR THE EVALUATION OF ARTHRITIS AND BIOLOGIC MARKERS OF INFLAMMATION. Annals of the Rheumatic Diseases. 2025; 84:556.

Vijayarajan, SAL; Krolick, KN; Quayle, K; Pilipenko, V; Glynn, S; Lacagnina, MJ; Martin, LJ; Lages, CS; Thornton, S; Garcia, V; Chidambaran, V. Potential role for immune cell signatures as predictors of acute and chronic pain in adolescents post major musculoskeletal surgery. Brain, Behavior, and Immunity. 2026; 131:106133.

Wallace, PK; Jellison, ER; Thornton, S; Kluepfel, K; Back, J; Beadnell, TC; Bebes, A; Behrends, J; Belkina, AC; Black, M; Woolard, S; Yeh, N-Y; Yuecel, R; Rajwa, B. Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference Workshops. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 2025.

Weiss, PF; Ruperto, N; Quebe-Fehling, E; Shew, A; Pricop, L; Pieterse, CC; Brunner, HI. Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting. Journal of Rheumatology. 2026; 53(1):85-94.

Wendroth, R; Paisley, A; Marsh, R; Schulert, G; Wikenheiser-Brokamp, KA; Burg, G. Lung Disease in Systemic Juvenile Idiopathic Arthritis: An Atypical Path to Diagnosis. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Abstracts):a7865-a7865.

Wuller, S; Singer, NG; Lewis, C; Karlson, EW; Schulert, GS; Goldman, JD; Hadlock, J; Arnold, J; Hirabayashi, K; Stiles, LE; Johnson, SG; Stroebel, S; Wallace, ZS; Costenbader, KH. Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts. PLoS ONE. 2025; 20(6):e0324513.

Yung, EM; Fridley, A; Matheny, T; Brunner, HI. Navigating the Biosimilars from Bench to Bedside in Juvenile Idiopathic Arthritis. Paediatric Drugs. 2025; 27(6):679-691.

Zhao, J; Zhao, X; Mizuno, T; Irie, K; Devarajan, P; Brunner, HI; Setchell, KDR. Volumetric Absorptive Microsampling Combined with Mass Spectrometry to Support Pharmacokinetically-Guided Precision Dosing of Mycophenolate Mofetil in Pediatric Lupus Nephritis Patients. Journal of Applied Laboratory Medicine. 2025; 10(4):806-819.